# Great Lakes Node of the Drug Abuse Clinical Trials Network

> **NIH NIH UG1** · RUSH UNIVERSITY MEDICAL CENTER · 2020 · $422,584

## Abstract

Project Summary/Abstract
In alignment with RFA-DA-19-008, this application seeks to establish the Great Lakes Node (GLN) of the
NIDA-supported Drug Abuse Clinical Trials Network (CTN). This node will draw on an experienced set of
investigators who have active collaborations and represent all of the major academic medical centers in the
Greater Chicago and Wisconsin areas. The node will serve as a vital Midwestern hub for the CTN and will
expand on the success of the CTN approach. In addition, the GLN will bring substantial experience in
adolescent/young adult research, seniors/aging research, digital & mobile technologies, opioid misuse,
collaborative care/population health, telehealth, and electronic health record and systems-driven interventions
and research methodologies.
The GLN will support engagement with CTN protocols and also add the following:
Aim 1: GLN will identify and recommend substance misuse research and intervention protocols focused on
systems-based practice using hospital-based screening, collaborative care, and population approaches.
Aim 2: We will establish a digital and computation health core that will leverage our expertise in these domains
and serve as a conduit for studies in mHealth, eHealth, artificial intelligence, natural language processing, and
telehealth interventions.
Aim 3: Our node will bring substantial expertise with youth/adolescent health and seniors/aging that will enable
us to recommend studies to the CTN that examine the genesis of substance misuse and the potential for
prevention strategies to mitigate these life-course pathways.
Aim 4: In alignment with our team’s expertise, we plan to support work on substance and opioid misuse that
focuses on health disparities including socioeconomic, geographic, sexual orientation, and gender identity.
Aim 5: Leveraging our experience in professional education and practice-based learning, our node will
rigorously test the impact of professional education on opioid and substance treatment. We have built on the
ECHO model to develop methods to conduct high-quality distance education and supported training that are
currently being trialed in Illinois with plans to expand these programs nationally.
Aim 6: GLN will expand the pipeline of early investigators interested in substance misuse research. We will
align this part of our program with our very successful CTSA-supported programs and build specific
subprogramming that supports addiction and substance misuse research, training, and mentorship.

## Key facts

- **NIH application ID:** 9956715
- **Project number:** 5UG1DA049467-02
- **Recipient organization:** RUSH UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Niranjan Subhash Karnik
- **Activity code:** UG1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $422,584
- **Award type:** 5
- **Project period:** 2019-06-15 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9956715

## Citation

> US National Institutes of Health, RePORTER application 9956715, Great Lakes Node of the Drug Abuse Clinical Trials Network (5UG1DA049467-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9956715. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*